Health CareHealth Care Equipment & Services
  • Price (USD)198.93
  • Today's Change3.34 / 1.71%
  • Shares traded1.66m
  • 1 Year change-7.17%
  • Beta0.7578
Data delayed at least 15 minutes, as of Dec 06 2019 23:30 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Cigna Corporation is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company's segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate. Its Global Health Care segment aggregates the commercial and Government operating segments. Its commercial operating segment encompasses the United States commercial and certain international healthcare businesses serving employers and their employees, other groups, and individuals. Its Global Supplemental Benefits segment offers supplemental health, life and accident insurance products in selected international markets and in the United States. Its Group Disability and Life segment provides group long-term and short-term disability insurance, group life insurance, accident and specialty insurance and related services.

  • Revenue in USD (TTM)129.64bn
  • Net income in USD4.27bn
  • Incorporated2018
  • Employees73.80k
  • Location
    Cigna Corp900 Cottage Grove RdBLOOMFIELD 06002-2920United StatesUSA
  • Phone+1 (860) 226-6000
  • Fax+1 (302) 655-5049
  • Websitehttps://www.cigna.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Principal Financial Group Inc15.99bn1.33bn14.90bn16.48k11.371.019.450.9324.724.7256.6653.250.0604----970,397.600.51440.6176--------8.5111.14--2,009.380.203535.100.64418.69-9.7611.949.2216.47
AFLAC Incorporated21.92bn3.05bn38.90bn11.39k13.061.32--1.774.064.0529.0940.040.1501----1,924,
Anthem Inc100.22bn4.27bn72.33bn63.90k17.472.3113.640.721816.3316.44382.80123.461.32----1,568,341.005.614.33--------4.263.34--8.330.392323.702.295.3136.117.1613.3214.87
Cigna Corp129.64bn4.27bn74.29bn73.80k17.471.6610.220.57311.3911.38368.57119.641.09----1,756,653.003.603.29--------3.315.48--4.080.46420.456716.638.446.7212.290.03790.00
UnitedHealth Group Inc239.67bn13.34bn265.46bn300.00k20.384.8216.211.1113.7513.75246.9658.071.48----798,903.308.467.04--------5.734.51--11.630.42928.9012.4713.0628.0816.339.5626.80
Data as of Dec 06 2019. Currency figures normalised to Cigna Corp's reporting currency: US Dollar USD

Institutional shareholders

42.58%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 201928.23m7.48%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 201923.85m6.32%
Capital Research & Management Co. (World Investors)as of 30 Sep 201920.11m5.33%
Dodge & Coxas of 30 Sep 201917.38m4.60%
BlackRock Fund Advisorsas of 30 Sep 201916.51m4.37%
SSgA Funds Management, Inc.as of 30 Sep 201916.13m4.27%
Fidelity Management & Research Co.as of 30 Sep 201911.28m2.99%
Massachusetts Financial Services Co.as of 30 Sep 201910.93m2.90%
Capital Research & Management Co. (Global Investors)as of 30 Sep 20199.49m2.51%
Capital Research & Management Co. (International Investors)as of 30 Sep 20196.90m1.83%
More ▼
Data from 30 Sep 2019 - 30 Sep 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.